FDA OKs Hizen­tra for rare au­toim­mune dis­ease CIDP

Just one day af­ter get­ting cleared to sell its new rare dis­ease drug Hizen­tra in Eu­rope, Penn­syl­va­nia drug­mak­er CSL Behring got the green light from …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.